Cisplatin

顺铂

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameCisplatin
Drug Alias Namecisplatine氯氨铂顺-二氯二氨络铂cisplatinoCisplatinum +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agentsDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsBone metastasesChemotherapy induced poisoningOropharyngeal Squamous Cell Carcinoma (OPSCC) +[73] 
Global Approved IndicationsSolid tumoursUrinary Bladder NeoplasmsTesticular Neoplasms +[4] 
Approved Indications in ChinaSolid tumours
Original Approved Country/TerritoryUnited States
Original Approved Date1978/12/19
Country/TerritoryCzechiaBelgiumBulgaria +[43] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHq Speciality Pharma
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteAmrita Institute Of Medical Sciences & Research CenterHefei University Of Technology +[39] 
Inactive CompaniesUtah State UniversityCanadian Institutes Of Health Research (Cihr)Ajou University +[39] 
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Oral Squamous Cell CarcinomaSolid tumours +[38] 
Inactive IndicationsBone metastasesChemotherapy induced poisoningHormone-Resistant Prostate Neoplasms +[35] 

Other Information

ATC CodeL01XA01
Related LinksWikipediaDrugBankKEGG